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Obesity has recently emerged as a major global healthproblem. According to World Health Organization esti-
mates, 1.6 billion adults worldwide were overweight (body
mass index [BMI] 25 kg/m2) and at least 400 million were
obese (BMI 30 kg/m2) in 2005, numbers that are expected
to reach 2.3 billion and 700 million, respectively, by 2015. In
the United States, the percentage of overweight and obese
adults increased markedly from 47% and 15% in 1976 to
1980 to 66% and 33% in 2005 to 2006, with the greatest
proportion of increase seen among non-Hispanic black and
Mexican American women.1,2 The implications of excess
body weight are far-reaching. Epidemiological studies indi-
cate that overweight and obesity are important risk factors for
type 2 diabetes mellitus (T2DM), cardiovascular disease,
cancer, and premature death.3 In the United States, healthcare
expenditures attributable to overweight and obesity are esti-
mated to be $147 billion or 9.1% of total healthcare costs per
year.4 Such excess costs could have serious repercussions for
resource-poor countries, which must manage the dual burdens
of chronic and infectious disease.
In the setting of a pandemic of obesity and related chronic
diseases, the American Heart Association recently released a
scientific statement recommending reductions in added-sugar
intake to no more than 100 to 150 kcal/d for most Ameri-
cans.5 The statement identified sugar-sweetened beverages
(SSBs) as the primary source of added sugars in the American
diet.6 Although it has long been suspected that SSBs contrib-
ute at least in part to the obesity epidemic, only in recent
years have large epidemiological studies been able to sub-
stantiate the relationship between SSB consumption and
long-term weight gain, T2DM, and cardiovascular risk. It is
thought that SSBs contribute to weight gain because of their
high added-sugar content, low satiety, and potential incom-
plete compensation for total energy, leading to increased
energy intake.7,8 In addition, because of their high amounts of
rapidly absorbable carbohydrates such as various forms of
sugar and high-fructose corn syrup (HFCS) and the large
quantities consumed, SSBs may increase T2DM and cardio-
vascular risk independently of obesity as a contributor to a
high dietary glycemic load (GL), leading to inflammation,
insulin resistance, and impaired -cell function.9 Fructose
from any sugar or HFCS may also increase blood pressure
and promote the accumulation of visceral adiposity, dyslip-
idemia, and ectopic fat deposition because of increased
hepatic de novo lipogenesis.10 Here, we review temporal
patterns in SSB consumption and clinically relevant effects
on obesity, T2DM, and cardiovascular disease risk, empha-
sizing potential underlying biological mechanisms, clinical
implications, and consideration of methodological issues
inherent in the literature.
SSB Global Pattern
Although carbonated beverages trace their history back to the
1760s when carbonation techniques were developed to repro-
duce naturally occurring carbonated mineral waters believed
to be healthy, these beverages did not add sugar.11 A century
later, one of the most pivotal events in soft drink history
occurred when Atlanta pharmacist J.S. Pemberton combined
kola, a caffeinated nut from Africa, with coca, a stimulant from
South America, to create Coca-Cola, which, like most other
sweetened beverages developed in the 1800s, was marketed as a
tonic.12 In about 1904, Asa Candler purchased legal rights to the
formula from Pemberton and soon developed the first mass
factory.13 During World War II, Coca-Cola worked closely with
the US Department of War to provide free Cokes to army
soldiers. As a result of a lobbying campaign, they were allowed
to break sugar ration rules and to create Coke plants in European
countries with the support of the government, ultimately becom-
ing synonymous globally with SSBs.13
During the past 30 years, there has been a marked increase
in the consumption of SSBs across the globe. For instance, in
the United States, intake of these beverages, which includes
the full range of soft drinks, fruit drinks, energy drinks, and
vitamin water drinks, increased from 3.9% of calories in the
late 1970s to 9.2% in 2001, representing a 3-fold increase in
intake.14 In other countries, there have been varying levels of
increase in SSBs, with some countries such as Mexico
reaching such magnitudes that serious government interven-
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tion to reduce intake is being undertaken.15 Nation-level food
disappearance data from China, India, Vietnam, Thailand,
and other South Asian countries also show rapid trajectories
of an increase in SSB intake, as well as large per capita
consumption across the Americas, Germany, Australia,
Spain, and Great Britain.16 The most rigorous sources of
nationally representative patterns in SSB intake come from
the United States and Mexico, where large-scale dietary
intake surveys have been repeated in the last decade.15,17
According to these data, all age groups in Mexico consume
10% of their total energy intake from SSBs. As shown in
Figure 1A, SSB intake has increased considerably among
those5 years of age in Mexico. Figure 1B presents the same
data for the United States. As seen in both children 2 to 18
years of age and adults 19 years of age, substantial
increases across each decade have continued.
SSB and Childhood Obesity
Childhood obesity is known to increase risk of obesity in
adulthood and can lead to serious consequences for T2DM and
cardiovascular disease risk later in life. In fact, recent evidence
suggests consideration of lipid screening for children with BMI
beginning at the 80th percentile rather than85th percentile, the
point at which a child is considered overweight.18
Given the preponderance of SSB consumption among
children and adolescents, several epidemiological studies
have examined the relationship between SSB and weight gain
or obesity in this group. Recently, we conducted a meta-anal-
ysis evaluating change in BMI per increase in 1 serving of
SSB per day and found a significant positive association
between SSB intake and weight gain (0.08; 95% confidence
interval [CI], 0.03 to 0.13 kg)19 among studies that did not
adjust for total energy intake.20–24 Because the association
between SSB intake and weight gain is partially mediated by
total energy intake, adjusting for energy is expected to
attenuate this effect. In these data, the effect was also
strongest in larger studies with longer durations of follow-up
that used robust dietary assessment methods such as food
frequency questionnaires rather than a single 24-hour diet
recall, which is not able to capture patterns in dietary
intake.20,21 These results are supported by previous systematic
reviews and meta-analyses,25–27 as well as more recent
studies. For example, Dubois and colleagues28 found that in
2000 children 2.5 years of age followed up for 3 years,
regular consumers of SSBs between meals had a 2.4-fold
greater odds of being overweight compared with nonconsum-
ers (P0.05). Another study conducted among 5-year-old
subjects in the UK with 4 years of follow-up did not find an
association between SSB intake and fatness, possibly because
intake levels were too low.29 Recent studies have also shown
that greater SSB consumption in childhood or adolescence
predicted weight gain into adulthood.30,31
Findings from intervention studies, which are few in
number, generally support those from well-powered prospec-
tive cohort studies and show positive associations between
SSB intake and weight gain either in the overall study22 or in
subgroup analyses among participants overweight at base-
line.24,32 A follow-up analysis of a school-based intervention
that showed that reducing SSB intake decreased overweight
and obesity22 did not see an effect 2 years after the interven-
tion had been discontinued, which supports an effect of SSB
consumption on weight gain.33
SSB Consumption and Weight Gain in Adults
To date, a large number of studies have evaluated the
relationship between SSB consumption and weight gain or
Figure 1. Trends in consumption of calories from soft drinks and all caloric beverages in Mexico and the United States (weighted to be
nationally representative) by age groups (1 to 4, 5 to 11, 12 to 18, and 19 years) in 1999 and 2006. Soft drinks include carbonated,
noncarbonated beverages with sugar added, and commercially processed, bottled/formula fountain soft drinks and fruit drinks but
exclude agua frescas, Mexican hand-prepared added-sugar fruit juices, and fruit drinks.
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risk of overweight and obesity among adults. However,
differences in study design, methodologies, and data quality
have made it difficult to observe a consistent effect. Cross-
sectional studies are not optimal because of the high potential
for intractable confounding and reverse causation. Experi-
mental studies are not well suited to capture long-term
patterns because compliance tends to wane with increasing
duration, but they do provide important insight into potential
underlying biological mechanisms. Prospective cohort studies
tend to provide the most robust evidence despite a large
degree of diversity between studies in terms of outcome
measurements, size, and duration of follow-up. Therefore,
greater emphasis should be placed on larger studies of longer
duration that are better powered to detect an effect. In this
literature, the longest and largest studies34,35show stronger
and more consistent associations compared with smaller and
shorter studies.36,37 For example, in the study by Schulze et
al34 of 50 000 nurses followed up for two 4-year periods
(1991 to 1995 and 1995 to 1999), a higher consumption of
SSBs was associated with a greater magnitude of weight gain.
After adjustment for potential confounders, women who
increased their SSB consumption from 1991 to 1995 and
maintained a high level of intake gained on average 8.0 kg
during the 2 periods, whereas women who decreased their
SSB intake between 1991 and 1995 and maintained a low
level of intake gained on average 2.8 kg during the 2 periods
(Figure 2). Similar results were reported by Palmer and
colleagues35 in 40 000 black women followed up for 6
years. Those whose SSB intake increased from 1 serving
per week to 1 serving per day gained the most weight,
whereas those who decreased their intake gained the least
weight (6.8 and 4.1 kg, respectively) after adjustment for
potential confounders. A smaller study from Spain38 with
7000 participants followed up for 2 years found that a
higher consumption of SSB was associated with significant
weight gain among subjects who gained 3 kg in the 5 years
before baseline. These participants had a higher absolute
intake of SSB at baseline compared with participants with no
previous weight gain, consistent with a positive association
between SSB intake and weight gain. It is possible that the
study was not long enough to evaluate weight gain in relation
to SSB intake in subjects with no previous weight gain. In a
large cohort from Germany (n17 369) with a similar dura-
tion of follow-up, SSB intake was associated with weight
gain in men but not women.39 In the Framingham Offspring
Study40 with an average duration of 4 years and 4000
participants, compared with infrequent consumers, partici-
pants who consumed1 soft drinks per day had a 37% higher
risk of obesity.40 Because this analysis included both diet and
regular soft drinks, it is difficult to disentangle the inde-
pendent effect of SSBs because consumers of diet soft
drinks may be weight conscious or trying to lose weight. In
an observational analysis of the Clinical Trial of Compre-
hensive Lifestyle Modification for Blood Pressure Control
(PREMIER) study (n810), Chen et al41 found that a
reduction in SSB intake of 1 serving per day was associated
with a weight loss of 0.49 kg (95% CI, 0.11 to 0.82;
P0.006) at 6 months and of 0.65 kg (95% CI, 0.22 to 1.09;
P0.003) at 18 months. However, participants in this study
were part of a trial to lower blood pressure and had higher
baseline BMI than other cohorts and stage 1 hypertension,
which could partly explain why such a strong effect was seen
with relatively little power. At the same time, because this
study adjusted for total energy, the effect of SSBs on weight
gain may have been underestimated.
SSB Consumption and T2DM and the
Metabolic Syndrome
Similar to the weight-gain literature, prospective cohort
studies evaluating the effect of SSBs on risk of T2DM and the
metabolic syndrome (MetSyn) have found the strongest and
most consistent associations in large studies with long dura-
tions of follow-up. These aspects of study design are partic-
ularly important when assessing diet in relation to chronic
disease origin because sufficient time is required for causal
action and disease initiation and detection to occur. In
50 000 women followed up for 8 years, after adjustment for
potential confounders, those consuming1 SSBs per day had
an 83% greater risk of developing T2DM compared with
those consuming1 SSB per month (relative risk [RR], 1.83;
95% CI, 1.42 to 2.36; P0.001 for trend; Figure 3).34 The RR
comparing extreme categories further controlling for BMI
was 1.41 (95% CI, 1.09 to 1.83; P 0.001 for trend). This
finding suggests that BMI accounts for about half of the
excess risk. Similarly, in the Black Women’s Health Study,35
with 40 000 women followed up for 10 years, those who
consumed 2 SSBs per day had a 24% greater risk of
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Figure 2. Low and high intakes were
defined as 1/week and 1/day. The
numbers of subjects were as follows:
low-high-high323, low-high-low461,
high-low-high110, and high-low-
low746. Groups with similar intake in
1991 and 1995 were combined for esti-
mates for these time points. Means were
adjusted for age, alcohol intake, physical
activity, smoking, postmenopausal hor-
mone use, oral contraceptive use, cereal
fiber intake, and total fat intake at each
time point. Adapted with permission
from Schulze et al.34
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developing T2DM compared with those who consumed 1
SSB per month (RR, 1.24; 95% CI, 1.06 to 1.45; P0.002 for
trend). After additional adjustment for BMI, the RR was no
longer statistically significant, suggesting that in this popula-
tion the majority of effect was mediated by BMI. Findings
from these studies were replicated in a large cohort of
70 000 women followed up for 18 years that showed that
women who consumed 2 to 3 SSBs per day had a 31% greater
risk of developing T2DM than women who consumed 1
SSB per month (RR, 1.31; 95% CI, 0.99 to 1.74; P0.01 for
trend).42 Because this study adjusted for BMI and total energy
intake, both potential mediators of effect, the association
between SSB intake and T2DM risk may actually be under-
estimated. In contrast to these studies, findings from the
Atherosclerosis Risk in Communities Study (n12 204) did
not show a consistent association between SSB intake and
incidence of T2DM after 9 years of follow-up (men: RR,
1.09; 95% CI, 0.89 to 1.33; women: RR, 1.17; 95% CI, 0.94
to 1.46).43 Compared with the study by Schulze et al,34
participants in this study were older (53.6 versus 36.1 years of
age) and heavier (27.2 versus 24.6 kg/m2) at baseline.
Because the effect of SSB on T2DM is mediated in part by
BMI, once BMI is increased, it is possible that the additional
effect of continued SSB intake is diminished; however,
further research is needed to confirm this hypothesis.
Few studies have examined the effect of SSBs on the
development of MetSyn, but they are in line with findings
from studies evaluating T2DM. For example, findings from
the Framingham Offspring Study (n6154) showed that
compared with nonconsumers, individuals who consumed1
soft drinks per day had a 39% greater risk of developing
MetSyn during the course of 4 years.40 Although this analysis
combined diet and regular soft drinks, it can be assumed that
the majority of this effect was due to regular soft drink
consumption. Other studies of MetSyn have found marginal
effects of SSBs, but because they adjusted for total energy
intake, the results may have been underestimated.44,45
SSB Consumption and Cardiovascular Risk
The evidence relating SSB intake to cardiovascular risk is
limited, although data are starting to accumulate that suggest
that greater SSB consumption may have a role in the
development of hypertension, adverse lipid parameters, in-
flammation, and clinical coronary heart disease (CHD). The
Framingham Offspring Study, which also looked at SSB
intake in the context of MetSyn components in 6154 adults
followed up for 4 years, found that individuals who consumed
1 soft drink per day had a 22% higher incidence of
hypertension (135/85 mm Hg or on treatment) compared
with nonconsumers (RR, 1.22; 95% CI, 1.05 to 1.41).40
Similarly, in the Nurses’ Health Studies I and II, women who
consumed 4 SSBs per day had a 44% and 28% higher risk
of incident hypertension, respectively, compared with infre-
quent consumers (RR, 1.44; 95% CI, 0.98 to 2.11; and RR,
1.28; 95% CI, 1.01 to 1.62, respectively).46 Regarding lipids,
daily soft drink consumers in the Framingham Offspring
Study were found to have a 22% higher incidence of
hypertriglyceridemia (1.7 mmol/L or on treatment) and low
high-density lipoprotein cholesterol (1.03 mmol/L for men
or 1.3 mmol/L for women or on treatment) compared with
nonconsumers (RR, 1.22; 95% CI, 1.07 to 1.41; and RR, 1.22;
95% CI, 1.04 to 1.44, respectively).40 Results from the
Multi-Ethnic Study of Atherosclerosis (MESA) study, which
had fewer participants (n3878), showed a significant effect
of SSBs on hypertriglyceridemia (1.7 mmol/L or on treat-
ment) and trends toward an effect on hypertension (130/
85 mm Hg or on treatment) and low high-density lipoprotein
cholesterol (1.03 mmol/L for men or 1.3 mmol/L for
women or on treatment) in daily SSB consumers compared
with nonconsumers (RR, 1.28; 95% CI, 1.02 to 1.60; RR,
1.14; 95% CI, 0.91 to 1.43; and RR, 1.28; 95% CI, 0.99 to
1.64, respectively).45 These findings are supported by a recent
cross-sectional analysis of National Health and Nutrition
Examination Survey data that found a positive association
between SSB intake and blood pressure in adolescents.47 A
10-week intervention study comparing the effects of sucrose-
and artificially sweetened foods/beverages on markers of
inflammation found that serum levels of haptoglobin, trans-
ferrin, and C-reactive protein increased in the sucrose group
and decreased in the sweetener group (between-group differ-
ences: P0.006, P0.01, and P0.1, respectively).48 Indi-
rect evidence for an effect of SSBs on inflammation also
stems from observational studies that have found positive
associations between dietary patterns that are high in SSBs
with markers of inflammation such as C-reactive protein and
tumor necrosis factor receptor 249 and dietary GL, to which
SSB intake is a large contributor with C-reactive protein.50 In
addition, higher consumption of soft drinks has been associ-
ated with hyperuricemia51 and incidence of developing
gout,52 a condition commonly associated with insulin resis-
tance and MetSyn.
Recently, in the Nurses Health Study, a positive associa-
tion between SSB intake and risk of CHD (nonfatal myocar-
dial infarction or fatal CHD) was observed even after ac-
counting for other unhealthy factors.53 In 88 000 women
followed up for 24 years, those who consumed 2 SSBs per
day had a 35% greater risk of developing CHD compared
with those who consumed1 SSB per month (RR, 1.35; 95%
CI, 1.1 to 1.7; P0.001 for trend). Additional adjustment for
BMI, energy intake, and incident T2DM attenuated the
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Figure 3. Multivariate RRs were adjusted for age, alcohol (0, 0.1
to 4.9, 5.0 to 9.9, 10 g/d), physical activity (quintiles), family
history of diabetes mellitus, smoking (never, past, current), post-
menopausal hormone use (never, ever), oral contraceptive use
(never, past, current), intake (quintiles) of cereal fiber, magne-
sium, trans fat, polyunsaturated:saturated fat, and consumption
of sugar-sweetened soft drinks, diet soft drinks, fruit juice, and
fruit punch (other than the main exposure, depending on
model). These data are based on data from Schulze et al.34
Malik et al Sugar-Sweetened Beverages 1359
 by guest on A
pril 3, 2018
http://circ.ahajournals.org/
D
ow
nloaded from
 
associations, but they remained statistically significant, sug-
gesting that the effect of SSBs on CHD is not entirely
mediated by these factors.
Potential Mechanisms
The prevailing mechanisms linking SSB intake to weight gain
are decreased satiety and incomplete compensatory reduction
in energy intake at subsequent meals after consumption of
liquid calories (Figure 4).7,8 On average, SSBs contain 140 to
150 calories and 35 to 37.5 g sugar per 12-oz serving. If normal
dietary intake does not decrease by an equivalent amount of
calories per serving, then weight gain is expected.25,54 This has
been illustrated in short-term feeding trials showing greater
energy intake and weight gain after consumption of calori-
cally sweetened beverages (sugar, sucrose, HFCS) compared
with noncaloric artificially sweetened beverages.55,56 In addi-
tion, a number of studies have shown greater energy intake
and weight gain after isocaloric consumption of beverages as
opposed to solid food.7 These studies argue that sugar or
HFCS in liquid beverages may not suppress intake of solid
foods to the level needed to maintain energy balance; how-
ever, the mechanism responsible for that weaker compensa-
tory response to fluids is unknown.57
SSBs may contribute to T2DM and cardiovascular risk in
part by their ability to induce weight gain, but an independent
effect may also stem from the high amounts of rapidly
absorbable carbohydrates such as any form of sugar or HFCS,
the primary sweeteners used in SSBs (Figure 4). Consump-
tion of SSBs has been shown to result in rapid and dramatic
increases in blood glucose and insulin concentrations,58
which, in conjunction with the large quantities that are often
consumed, contribute to a high dietary GL. High-GL diets are
thought to stimulate appetite and to promote weight gain and
have been shown to induce glucose intolerance and insulin
resistance.59 An increase in GL has also been shown to
exacerbate levels of inflammatory biomarkers such as
C-reactive protein linked to T2DM and cardiovascular dis-
ease risk.50 Inflammation is known to influence atherosclero-
sis, plaque stability, and thrombosis; therefore, SSB con-
sumption may affect CHD risk within just a few years.53 High
dietary GL has also been associated with greater risk of
CHD.60 In addition, the caramel coloring used in cola-type
soft drinks is high in advanced glycation end products, which
may further increase insulin resistance and inflammation.61
For instance, an 8-oz serving of cola delivers 16.3 kU
advanced glycation end products.62
Recent evidence also suggests that consuming fructose,
which is found in similar amounts in sucrose and HFCS, may
have particularly adverse effects on selective deposition of
visceral and ectopic fat, lipid metabolism, de novo lipogen-
esis, blood pressure, and insulin sensitivity compared with
glucose10 (Figure 4). The different pathways for the metab-
olism of fructose and glucose are clearly important potential
mechanisms. Fructose alone is poorly absorbed but is en-
hanced by glucose in the gut, thus accounting for the rapid
and complete absorption of both fructose and glucose when
ingested as sucrose or HFCS. Studies in humans and animals
have shown that fructose is preferentially metabolized to lipid
in the liver, leading to increased triglyceride levels, which
have been associated with the development of insulin resis-
tance and cardiovascular disease.63–66 A recent study in
overweight adults compared the effects of consuming
glucose- or fructose-sweetened beverages providing 25% of
energy requirements.10 After 10 weeks, both groups showed
similar weight gain; however, only the fructose group showed
a significant increase in visceral adiposity, which has also
been observed in a number of recent studies.67–69 Although
fasting plasma triglyceride levels increased only in the
glucose group, hepatic de novo lipogenesis, postprandial
triglycerides, and markers of altered lipid metabolism and
lipoprotein remodeling such as fasting apolipoprotein B and
small low-density lipoprotein particles significantly increased
in the fructose group. In addition, fasting plasma glucose and
insulin levels increased and insulin sensitivity decreased in
the fructose group. Of interest, Ghanim and colleagues70 did
not find evidence of oxidative or inflammatory stress after
intake of 300 kcal fructose or orange juice, whereas reactive
oxygen species generation and nuclear factor-B binding
were significantly increased after intake of glucose. However,
the quantities of fructose contained in SSBs are far greater
than those contained in these preloads.70 Fructose can also
increase blood uric acid concentrations.71 The production of
uric acid in the liver by xanthine oxidase may reduce
endothelial nitric oxide,72 which could partly mediate the
association between SSBs and risk of CHD. Increases in
blood pressure have also been observed when fructose is
administered acutely, an effect not seen with glucose.73 In
addition, an increase in blood pressure spanning 10 weeks
was found when individuals drank SSBs but not aspartame-
sweetened beverages.55 Fructose intake may also lead to
weight gain by decreasing the production of insulin and leptin
in peripheral tissues, thereby initiating the hunger cascade in
the central nervous system64; this area warrants further
investigation because others have found greater satiety and
lower total energy intake after fructose preloads compared
with glucose preloads.74
Clinical Implications
Controlling the intake of SSBs represents an important
component of lifestyle management for weight control and
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Figure 4. SSBs may lead to weight gain as a result of incom-
plete compensation for liquid calories at subsequent meals,
resulting in positive energy balance. Independently of weight
gain, SSBs may increase the risk of MetSyn, T2DM, and cardio-
vascular disease because of their large contribution to a high
dietary GL and large fructose fraction, leading to the develop-
ment of insulin resistance, -cell dysfunction, inflammation,
hypertension, visceral adiposity, and atherogenic dyslipidemia.
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maintenance. Limiting SSBs may also confer favorable ben-
efits on T2DM and cardiovascular risk such as improving
lipid profiles and insulin sensitivity and reducing blood
pressure, inflammation, and accumulation of visceral adipos-
ity. The excess risk imparted by SSBs may have particular
relevance for certain individuals or populations who are more
susceptible to developing T2DM.75 Limiting SSB intake
among children and adolescents is imperative because over-
weight and obesity are rampant in this population, which can
have serious downstream effects on cardiovascular health.
Public policy approaches such as taxation have been pro-
posed to reduce SSB consumption in the general population.76
When SSBs are replaced with other beverages, it is
important to select alternatives that are healthy and do not
promote weight gain. The average individual needs at least 1
mL fluid for every calorie burned, which is approximately
eight 8-oz glasses per day for a 2000-kcal diet.77 Adequate
hydration is essential for maintaining blood volume and
kidney function and preventing constipation.78 Water has no
calories or additives and is widely available, inexpensive, and
generally safe. Findings from epidemiological studies show
that energy intake is significantly lower (9%, or 194 kcal/d)
in water drinkers compared with non–water drinkers,79 which
was supported by a recent randomized controlled trial in
German schoolchildren.80 This study found that 1 year of
water intake was linked with a 31% reduction in the risk of
being overweight.80 Unlike SSBs, water does not contain
liquid calories to be compensated for at subsequent meals. As
shown in secondary analysis of a clinical weight loss trial,
replacing SSBs with water was associated with lower total
energy intake (predicted mean decrease of 200 kcal/d span-
ning 12 months).81 In addition, some evidence indicates that
consuming water before or with a meal reduces feelings of
hunger and increases satiety,79,82 in contrast to both diet and
regular soft drinks, which are thought to stimulate appetite by
their intense sweet flavor.83,84 Coffee and tea are also reason-
able alternatives provided that caloric sweeteners and whit-
eners are used sparingly. A number of studies have shown
that regular consumption of coffee and tea can have favorable
benefits on T2DM and cardiovascular disease risk, possibly
by virtue of their polyphenol content.85,86 In recent decades,
consumption of milk has decreased markedly in the United
States. Displacement by SSBs in the pediatric population is of
great concern because it can lead to lower intakes of protein,
calcium, magnesium, zinc, vitamin A, and vitamin D and
increase the risk for osteoporosis and bone fracture.14,87
Because of the excess calories and saturated fat content of
whole milk, low-fat milk is recommended but should be
consumed in moderation because one 8-oz serving of nonfat
milk still provides 85 kcal. Some evidence suggests that
low-fat dairy products may also be beneficial for weight loss
and the prevention of hypertension, T2DM, and CHD.88,89
Diet soda is a reasonable alternative to SSBs in that they
have few to no calories, but they provide no nutritional value,
and little is known about the health consequences of consum-
ing artificial sweeteners during a lifetime.90 In addition, some
evidence suggests that the intense sweetness of artificial
sweeteners could lead to conditioning for a greater preference
for sweets and thus may actually enhance appetite, but this
area remains controversial.91 Several epidemiological studies
have suggested a positive association between diet soda
consumption and weight gain and risk of MetSyn.40,44,45
However, these observations may be due to reverse causation
or residual confounding because, for example, diet soda
consumption is higher among individuals with diabetes mel-
litus than those without diabetes mellitus.92 Studies with
longer durations of follow-up and repeated measures, which
are less prone to reverse causation, showed only marginal
nonsignificant associations with diet soda.34,35,53 Some evi-
dence suggests that a subset of diet soda consumers use diet
soda as rationale for consuming other higher-calorie foods.90
There is also growing concern about excessive fruit juice
intake, but the evidence is limited. In a large cohort of
women, high intake of fruit juices was positively associated
with incidence of T2DM, whereas intake of whole fruits and
green leafy vegetables was inversely associated.42 Although
Schulze and colleagues did not find an association between
fruit juice and risk of T2DM, they did find a positive
association with weight gain.34 Fruit juice has also been
linked with increased weight among Australian children.93
However, Ghanim and colleagues observed significantly
lower reactive oxygen species generation and nuclear
factor-B binding after consumption of orange juice com-
pared with a glucose drink, possibly resulting from its
flavonoid content.70 Although fruit juice can provide some
vitamins and nutrients, they often contain high amounts of
sugar and calories and should therefore be consumed in
moderation.
Methodological Issues
Although more studies are warranted to better understand the
underlying biological mechanisms mediating the effect of
SSBs on weight gain, T2DM, and cardiovascular risk, evi-
dence from observational studies shows clear positive asso-
ciations. Clinical trials, on which policies and recommenda-
tions are often based, are not well suited to this modality
because they are greatly affected by intervention intensity and
are limited by compliance, which tends to wane with increas-
ing study length. To effectively evaluate the risk of chronic
disease, sufficient follow-up time is needed for causal action
and disease initiation and detection to occur, which would be
difficult to emulate in the setting of a clinical trial. Thus, in
the midst of an obesity epidemic that is fueling an epidemic
of T2DM and cardiovascular risk, ample evidence exists from
the observational studies at hand for nutrition recommenda-
tions and policy to discourage consumption of SSBs. How-
ever, certain limitations inherent in these studies are impor-
tant to consider when interpreting the evidence.
Most studies discussed here adjusted their analyses for
potential confounding by various lifestyle factors, and for the
majority, a positive association persisted, suggesting an
independent effect of SSBs. However, residual confounding
by unmeasured or imperfectly measured factors cannot be
ruled out. Higher SSB intake could be a marker of a globally
undesirable diet because it tends to cluster with other un-
healthy dietary and lifestyle habits such as higher intakes of
saturated and trans fats44,94 and higher GL.34 Therefore,
incomplete adjustment for various lifestyle factors could lead
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to an overestimation of the strength of the positive associa-
tions. However, the consistency of results from different
cohorts reduces the likelihood that residual confounding is
responsible for the findings. Because total energy intake
partially mediates the effect of SSBs on weight gain, T2DM,
and cardiovascular risk, whether a study has adjusted for total
energy intake can seriously affect its results. For example, in
our recent meta-analysis evaluating SSB intake and BMI in
children,19 when energy-adjusted estimates were excluded,
the summary effect estimate increased from a nonsignificant
inverse trend (0.03; 95% CI, 0.11 to 0.04) to a significant
positive association (0.08; 95% CI, 0.03 to 0.13). Even after
adjustment for total energy and other mediating factors such
as BMI, some studies have still shown positive associations,
supporting an effect of SSBs that is not mediated through
energy intake or adiposity.53,95,96 Measurement error in di-
etary assessment is inevitable. However, in the setting of
prospective cohort studies, misclassification of SSB intake
does not likely differ by case status. Such nondifferential
misclassification of exposure may actually attenuate the
associations. Awareness of weight status, however, could
result in systematic underreporting of SSB intake (as of body
weight), which could weaken the association of SSBs with
weight gain.
Longitudinal studies evaluating diet and weight change
may also be prone to reverse causation (ie, people change
their diet because of their weight, which could result in
spurious associations). Ascertainment of repeated measures
of diet and weight or stable intake patterns during long
periods of follow-up may reduce the likelihood of this.
Although most studies have been conducted among white
populations from the West, the underlying biological process
should be generalizable to other populations, although it is
possible that some ethnic groups may be more prone to the
deleterious effects of SSBs on cardiovascular risk. Further
work in this area is clearly warranted.
Conclusions
SSB intake has increased considerably across the globe in
recent decades, tracking positively with rising rates of obe-
sity. Given the large number of comorbidities, reduced
quality of life, and high healthcare expenditures, large-scale
obesity prevention efforts are now a priority for many
countries around the world. SSB intake is a significant
contributor to weight gain and can lead to increased risk of
T2DM and cardiovascular disease. In general, longer studies
with greater numbers of participants that do not adjust for
potential mediators of effect such as energy intake report
stronger and more consistent results. SSBs are the greatest
contributor to added-sugar intake in the United States and are
thought to promote weight gain in part because of incomplete
compensation for liquid calories at subsequent meals. SSBs
may also increase T2DM and cardiovascular risk indepen-
dently of obesity as a potential contributor to a high dietary
GL and increased fructose metabolism, leading to inflamma-
tion, insulin resistance, impaired -cell function, and high
blood pressure, as well as accumulation of visceral adiposity/
ectopic fat and atherogenic dyslipidemia. For these reasons
and because they have little nutritional value, intake of SSBs
should be limited, and SSBs should be replaced by healthy
alternatives such as water.
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